Nova Hub
EYRIS ANNOUNCES COLLABORATION WITH ICARE
23 Jan 2024 – We are thrilled to announce the successful conclusion of our collaborative agreement with iCare, marking a significant milestone in the world of eye care. The partnership will result in both companies working together to seamlessly integrate SELENA+ our AI for retinal diseases with iCare’s proprietary platform, ILLUME. ILLUME, developed by iCare, is a cutting-edge platform meticulously…
EYRIS APPOINTS PARTNER IN UAE
22 Jan 2024 – EyRIS is thrilled to announce that we have officially appointed One Health, a subsidiary of PureHealth, as our exclusive distributor within the United Arab Emirates (UAE). Recognized as the largest integrated healthcare provider in the UAE, PureHealth’s collaboration with EyRIS signifies the initiation of a transformative alliance poised to redefine healthcare standards across both public and…
EYRIS SELENA+ ATTAINS EU MEDICAL DEVICE REGULATION COMPLIANCE
Jan 2024 – A wonderful piece of news to kick-start the new year. A couple of years back, the EU Parliament legislated the transitional provisions from Medical Devices Directive (MDD) to Medical Devices Regulation (MDR). The new standard took into consideration the need for more stringent technical documentation, implementation of unique device identification (UDI) for better traceability and recall and…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 15 December 2023 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 400,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
EYRIS ANNOUNCES PARTNERSHIP WITH ADVANCE INNOVATION IN MYANMAR
Dec 2023 – EyRIS, the leading player in AI-driven healthcare solutions, is delighted to announce a strategic partnership with Advance Innovation, a collaboration that marks a momentous step forward in the enhancement and transformation of healthcare in Myanmar. The EyRIS team recently undertook a visit to Yangon, where they had the honor of engaging with distinguished medical professionals and key…
EYRIS SECURES NATIONAL SCREENING PROJECT IN SULTANATE OF OMAN
12 Dec 2023 – Nova MSC Berhad (“Nova MSC” or “the Company”), the parent company of EyRIS Pte Ltd (“EyRIS”), proudly announces that its state-of-the-art Artificial Intelligence (“AI”) tool, SELENA+, has been selected for the Sultanate of Oman’s National Diabetic Retinopathy (DR) Screening Program. This significant step underscores the global recognition and trust in EyRIS’s AI-driven solutions for enhancing healthcare…
OTHERS Press Release – Nova MSC’s Revolutionary AI Tool, SELENA+, Selected for Oman’s National DR Screening Program
NOVA MSC BERHAD 12 December 2023 Type Announcement Subject OTHERS Description Press Release – Nova MSC’s Revolutionary AI Tool, SELENA+, Selected for Oman’s National DR Screening Program Nova MSC Berhad (the “Company”) is pleased to attach a press release entitled “Nova MSC’s Revolutionary AI Tool, SELENA+, Selected for Oman’s National DR Screening Program”. Please refer to the attachment for…
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PROPOSED PLACEMENT”)
NOVA MSC BERHAD 30 November 2023 Type Announcement Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING Description NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PROPOSED PLACEMENT”) Reference made to the Company’s announcement dated…
MEMORANDUM OF UNDERSTANDING NOVA MSC BERHAD (“NOVA” or “Company”) – Memorandum of Understanding (“MOU”) between Theta Edge Berhad and NOVA
NOVA MSC BERHAD 30 November 2023 Type Announcement Subject MEMORANDUM OF UNDERSTANDING Description NOVA MSC BERHAD (“NOVA” or “Company”) – Memorandum of Understanding (“MOU”) between Theta Edge Berhad and NOVA We refer to the announcement dated 31 January 2023 in relation to the MOU between Theta Edge Berhad (“Theta”) and NOVA and the announcement dated 5 September 2023 in…
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2023
NOVA MSC BERHAD 23 November 2023 Financial Year End 31 Mar 2024 Quarter 2 Qtr Quarterly report for the financial period ended 30 Sep 2023 The figures have not been audited
SELENA+ USED AS TEACHING CASE FOR BUSINESS STUDENTS & CORPORATES WORLDWIDE
29 Nov 2023 – The development of SELENA+ is now used as a business teaching case about how a locally-developed eye screening artificial intelligence (AI) system from inception to commercialisation by the start-up EyRIS. The complete journey is documented by a Singapore Management University (SMU) team led by Professor Emeritus of Information Systems Steven Miller, the case is being distributed…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 30 November 2023 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 467,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$)…